Abstract
The prognosis of differentiated thyroid cancers (DTC) read at cytology as indeterminate and classified as Thy 3 according to the British Thyroid Association has recently been suggested to be good. To obtain robust information about this potential novelty, in this study we retrospectively reviewed DTC with a prior fine-needle aspiration cytology (FNAC) of Thy 3, Thy 4 or Thy 5 presently followed up at two institutes. Patients with no FNAC before surgery were excluded and a series of 284 DTC was enrolled in the study. Of these, 53 had Thy 3, 108 Thy 4, and 123 had Thy 5 prior to surgery. At histology, 280 (98.6 %) papillary and 4 follicular (1.4 %) cancers were found. Overall, the less aggressive cancer forms were prevalent in all three groups. The lower TNM stages (I and II) were more frequent in the Thy 3 group (96.2 %) than in the other cases (76.6 %) (p < 0.001). Neck lymph node metastasis at diagnosis was found in 3.8 % of Thy 3, 18.5 % of Thy 4, and 26 % of Thy 5 cases. At follow-up, a 16.2 % recurrence rate was recorded, ranging from 1.9 % in Thy 3 group to 19.5 % for Thy 4 and Thy 5 (p < 0.001). According to the Kaplan–Meier curve, Thy 3 was thus a favorable prognostic factor compared with Thy 4 and Thy 5 (OR = 0.079, p < 0.001, 95 %CI 0.01–0.59). At multivariate analysis, Thy 3 was an independent predictor of good prognosis (OR = 0.06, p = 0.03, 95 %CI 0.01–0.80). In conclusion, DTC with a preoperative Thy 3 cytology have a better prognosis than those with Thy 4 and Thy 5 due to less aggressive tumor types and lower TNM stage at diagnosis.
Similar content being viewed by others
References
S.I. Sherman, Thyroid carcinoma. Lancet 36, 501–511 (2003)
B.K. Kinder, Well differentiated thyroid cancer. Curr. Opin. Oncol. 15, 71–77 (2003)
J.L. Pasieka, Anaplastic thyroid cancer. Curr. Opin. Oncol. 15, 78–83 (2003)
S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti, Thyroid. AJCC Cancer Staging Manual, 7th edn. (Springer, NY, 2010), pp. 87–96
T. Rago, M. Scutari, F. Latrofa, V. Loiacono, P. Piaggi, I. Marchetti, R. Romani, F. Basolo, P. Miccoli, M. Tonacchera, P. Vitti, The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. J. Clin. Endocrinol. Metab. 9(10), 3700–3707 (2014)
Royal College of Physicians of London, Guidelines for the management of thyroid cancer, 2nd edn. (The Lavenham Press, Suffolk, 2007)
R.A. De Lellis, Pathology and genetics of tumours of endocrine organs, World Health Organization, 3rd edn. (IARC Press, Lyon, 2004)
L. Giovanella, G. Treglia, R. Sadeghi, P. Trimboli, L. Ceriani, F.A. Verburg, Unstimulated highly sensitive thyroglobulin in follow-up of differentiated thyroid cancer patients: a meta-analysis. J. Clin. Endocrinol. Metab. 99, 440–447 (2014)
P. Trimboli, D. La Torre, L. Ceriani, E. Condorelli, O. Laurenti, F. Romanelli, C. Ventura, A. Signore, S. Valabrega, L. Giovanella, High sensitive thyroglobulin assay on thyroxine therapy: can it avoid stimulation test in low and high risk differentiated thyroid carcinoma patients? Horm. Metab. Res. 45, 664–668 (2013)
S.Z. Ali, E.S. Cibas, The Bethesda system for reporting thyroid cytopathology. Thyroid 19, 1159–1165 (2009)
P. Trimboli, G. Treglia, L. Guidobaldi, E. Saggiorato, G. Nigri, A. Crescenzi, F. Romanelli, F. Orlandi, S. Valabrega, R. Sadeghi, L. Giovanella, Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis. Endocrine 46, 52–59 (2014)
M. Bongiovanni, A. Spitale, W.C. Faquin, L. Mazzucchelli, Z.W. Baloch, The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol. 56, 333–339 (2012)
A. Bartolazzi, F. Orlandi, E. Saggiorato, M. Volante, F. Arecco, R. Rossetto, N. Palestini, E. Ghigo, M. Papotti, G. Bussolati, M.P. Martegani, F. Pantellini, A. Carpi, M.R. Giovagnoli, S. Monti, V. Toscano, S. Sciacchitano, G.M. Pennelli, C. Mian, M.R. Pelizzo, M. Rugge, G. Troncone, L. Palombini, G. Chiappetta, G. Botti, A. Vecchione, R. Bellocco, Italian Thyroid Cancer Study Group (ITCSG): Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol. 9, 543–549 (2008)
P. Trimboli, E. Condorelli, A. Catania, S. Sorrenti, Clinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasm. Diagn. Cytopathol. 37, 783–785 (2009)
N. Nasrollah, P. Trimboli, L. Guidobaldi, D.D. Cicciarella Modica, C. Ventura, G. Ramacciato, S. Taccogna, F. Romanelli, S. Valabrega, A. Crescenzi, Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique. Endocrine 43, 659–665 (2013)
A. Heinzel, D. Müller, F.F. Behrendt, L. Giovanella, F.M. Mottaghy, F.A. Verburg, Thyroid nodules with indeterminate cytology: molecular imaging with 99mTc-methoxyisobutylisonitrile (MIBI) is more cost-effective than the Afirma® gene expression classifier. Eur. J. Nucl. Med. Mol. Imaging 41, 1497–1500 (2014)
L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295, 2164–2167 (2006)
P. Trimboli, S. Ulisse, F.M. Graziano, A. Marzullo, M. Ruggieri, A. Calvanese, F. Piccirilli, R. Cavaliere, A. Fumarola, M. D’Armiento, Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid 16, 1151–1155 (2006)
V.A. LiVolsi, S.L. Asa, The demise of follicular carcinoma of the thyroid gland. Thyroid 4, 233–236 (1994)
Conflict of interest
The authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Trimboli, P., Bongiovanni, M., Rossi, F. et al. Differentiated thyroid cancer patients with a previous indeterminate (Thy 3) cytology have a better prognosis than those with suspicious or malignant FNAC reports. Endocrine 49, 191–195 (2015). https://doi.org/10.1007/s12020-014-0453-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-014-0453-1